[1] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
[2] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[3] |
Du Yuhua, Feng Yajuan, Lei Yu, Lai Keng, He Weiyun.
Analysis of the detection and treatment of rifampicin-resistant pulmonary tuberculosis patients in Guangzhou during the “12th Five-Year Plan” and “13th Five-Year Plan” periods
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 678-686.
|
[4] |
Ge Fei, Zhu Hui, Cheng Kai, Lu Yu, Xu Jian.
Study on the determination of isoniazid and its metabolites concentration in plasma by high-performance liquid chromatography-mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 549-556.
|
[5] |
Ge Jing, Wang Jun, He Yuqi, Nie Wenjuan.
Six cases of pseudomembranous colitis caused by anti-tuberculosis drugs and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1320-1326.
|
[6] |
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong.
The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733.
|
[7] |
Peng Jiangli, Chen Jie, Chen Yonggang, Wang Lu, Li Na, Luo Ji, Han Yi, Yu Mingli, Zhu Jiangchun.
SLC22A12 gene polymorphism study on susceptibility to hyperuricemia induced by pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 151-158.
|
[8] |
TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan.
Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361.
|
[9] |
ZHOU Ting-ting, ZHENG Xiao-man, OUYANG Jing, LU Yan-qiu, CHEN Yao-kai.
Research progress on genes and mechanism of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 102-105.
|
[10] |
HU Yan-jie, GONG Shi-wei, REN Yi.
Establishment and evaluation of rapid detection of pyrazinamide resistance of Mycobacterium tuberculosis by probe enzyme digestion using Surveyor
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 813-816.
|
[11] |
CAO Pan, LIANG Kuang-li, YUAN Ji-xin, LI Yong-bo, CHEN Rui, ZHANG Zhi-fei, WU Qian-hong.
Analysis of CT findings in patients with initial and retreated cavernous rifampicin-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 694-701.
|
[12] |
SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei.
Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327.
|
[13] |
YANG Qing-luan, LIU Qi-hui, LIN Miao-yao, XU Yu-zhen, LIU Xue-feng, HE Zhang-yu-fan, HUANG Xi-tian, HAO Bin, SHAO Ling-yun, ZHANG Wen-hong, RUAN Qiao-ling.
A study of pharmacokinetic of rifapentine combined with isoniazid in the preventive treatment of tuberculosis in silicotic patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 228-232.
|
[14] |
WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin.
The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254.
|
[15] |
RUAN Yun-zhou, SU Wei, JIANG Jia-wen, LI Ren-zhong.
The effect of case finding of pulmonary tuberculosis and rifampicin resistance tuberculosis with GeneXpert MTB/RIF test in economic undeveloped areas
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1275-1279.
|